JAY DUKER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

EyePoint Pharmaceuticals, Inc.

Filing Date Source Excerpt
2017-05-15 Dr. Duker joined our Board on September 26, 2016. Dr. Duker did not hold any shares of Common Stock, nor did Dr. Duker have the right to acquire beneficial ownership of any shares of Common Stock within sixty (60) days of May 10, 2017.
2017-11-13 Dr. Duker received an A.B. from Harvard University and an M.D. from the Jefferson Medical College of Thomas Jefferson University.
2018-05-11 Jay Duker 45,833 *

Data sourced from SEC filings. Last updated: 2026-03-05